6 p

gemcitabinecarboplatin in patients with metastatic non–small-cell lung cancer phase ii study of 28-day and 21-day schedules

6 p

gemcitabinecarboplatin in a modified 21-day administration schedule for advanced-stage non-small-cell lung cancer

5 p

gemcitabinecapecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes

6 p

evolution of fluoroquinolone resistance among escherichia coli urinary tract isolates from a french university hospital application of the dynamic regression model

22 p

evolution of extended-spectrum β-lactamases by mutation

5 p

evolution of emission manners of organic light-emitting diodes from emission of singlet exciton to emission of doublet exciton

6 p

effects of sequential electron transfer on electron spin polarized transient epr spectra at high fields

9 p

effects of sensorimotor trunk impairments on trunk and upper limb joint kinematics and kinetics during sitting pivot transfers in individuals with a spinal cord injury